उत्पाद विवरण
Bonitar 400 mg Tablet is a targeted therapy designed for the treatment of chronic myeloid leukemia (CML), particularly in patients who have shown resistance to previous treatments. The active ingredient, Bosutinib, works by inhibiting specific proteins that promote the growth and proliferation of cancer cells, thereby helping to control the disease. It's crucial for patients to be aware of potential side effects, which may include diarrhea, nausea, and liver function changes, necessitating regular monitoring during treatment. Additionally, those with a history of liver disease or certain cardiovascular conditions should consult their healthcare provider before starting Bonitar. This medication is typically prescribed as part of a comprehensive treatment plan, tailored to each patient's unique needs. Patients are advised to adhere strictly to the dosage regimen to maximize the therapeutic benefits while minimizing risks. As with any anti-cancer therapy, ongoing communication with healthcare professionals is essential to ensure the best possible outcomes. Bonitar 400 mg Tablet represents a significant advancement in the fight against CML, offering hope for improved management of this challenging condition.
Send Email 
जांच भेजें
जांच भेजें
एसएमएस भेजें
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese